{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Descriptive&page=18", "query": { "intervention": "Descriptive", "page": 18 }, "page_size": 10 }, "pagination": { "page": 18, "page_size": 10, "total_count": 1588, "total_pages": 159, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Descriptive&page=19&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Descriptive&page=17&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T08:17:44.581Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03209349", "title": "Investigation of Cecal Intubation Rates and Pain Levels Between Water Exchange and Air Insufflation Flexible Sigmoidoscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "Water Exchange Sigmoidoscopy", "type": "PROCEDURE" }, { "name": "Air Insufflation Sigmoidoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Kelowna Gastroenterology Associates", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "50 Years to 74 Years" }, "enrollment_count": 90, "start_date": "2017-06-14", "completion_date": "2022-11-03", "has_results": false, "last_update_posted_date": "2022-11-07", "last_synced_at": "2026-10-25T08:17:44.581Z", "location_count": 1, "location_summary": "North Hills, California", "locations": [ { "city": "North Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03209349" }, { "nct_id": "NCT02652455", "title": "Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Melanoma (Skin)", "Skin Cancer" ], "interventions": [ { "name": "Nivolumab", "type": "DRUG" }, { "name": "Surgery to Remove Tumor for Growth of TIL", "type": "PROCEDURE" }, { "name": "CD137", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "TIL Infusion", "type": "BIOLOGICAL" }, { "name": "Interleukin-2", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BIOLOGICAL" ], "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2016-03-08", "completion_date": "2020-08-30", "has_results": false, "last_update_posted_date": "2025-08-19", "last_synced_at": "2026-10-25T08:17:44.581Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02652455" }, { "nct_id": "NCT02828358", "title": "Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Leukemia of Ambiguous Lineage", "B Acute Lymphoblastic Leukemia", "Mixed Phenotype Acute Leukemia" ], "interventions": [ { "name": "Azacitidine", "type": "DRUG" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Daunorubicin", "type": "DRUG" }, { "name": "Daunorubicin Hydrochloride", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Hydrocortisone Sodium Succinate", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Leucovorin Calcium", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Mercaptopurine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Pegaspargase", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" }, { "name": "Thioguanine", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Vincristine Sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "364 Days", "sex": "ALL", "summary": "Up to 364 Days" }, "enrollment_count": 78, "start_date": "2017-04-01", "completion_date": "2024-12-31", "has_results": true, "last_update_posted_date": "2025-02-27", "last_synced_at": "2026-10-25T08:17:44.581Z", "location_count": 157, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 128 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02828358" }, { "nct_id": "NCT07551921", "title": "PheCheck™ Validation Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Phenylketonuria (PKU) and Hyperphenylalaninemia" ], "interventions": [ { "name": "PheCheck", "type": "DEVICE" }, { "name": "Dried Blood Spot Cards.", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DEVICE", "DIAGNOSTIC_TEST" ], "sponsor": "Aptatek BioSciences, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": null, "sex": "ALL", "summary": "1 Year and older" }, "enrollment_count": 60, "start_date": "2026-08-20", "completion_date": "2027-04-20", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-10-25T08:17:44.581Z", "location_count": 2, "location_summary": "Chicago, Illinois • Boston, Massachusetts", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07551921" }, { "nct_id": "NCT02304393", "title": "A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumors" ], "interventions": [ { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Selicrelumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2014-12-12", "completion_date": "2019-11-07", "has_results": false, "last_update_posted_date": "2019-12-13", "last_synced_at": "2026-10-25T08:17:44.581Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02304393" }, { "nct_id": "NCT04954287", "title": "Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "CVXGA1 low dose", "type": "BIOLOGICAL" }, { "name": "CVXGA1 high dose", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "CyanVac LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 72, "start_date": "2021-08-06", "completion_date": "2023-06-10", "has_results": false, "last_update_posted_date": "2024-02-07", "last_synced_at": "2026-10-25T08:17:44.581Z", "location_count": 4, "location_summary": "Bardstown, Kentucky • Rochester, New York • Cincinnati, Ohio + 1 more", "locations": [ { "city": "Bardstown", "state": "Kentucky" }, { "city": "Rochester", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Plano", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04954287" }, { "nct_id": "NCT06164106", "title": "Feasibility Trial of a Single Session of Crisis Response Planning for Youth at High Risk for Suicide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Suicide Prevention" ], "interventions": [ { "name": "Virtual Crisis Response Planning", "type": "BEHAVIORAL" }, { "name": "In-Person Crisis Response Planning", "type": "BEHAVIORAL" }, { "name": "Crisis Risk Counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "14 Years to 18 Years" }, "enrollment_count": 57, "start_date": "2023-11-01", "completion_date": "2025-01-22", "has_results": true, "last_update_posted_date": "2026-03-18", "last_synced_at": "2026-10-25T08:17:44.581Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06164106" }, { "nct_id": "NCT04281849", "title": "Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Failure", "Heart Failure With Preserved Ejection Fraction", "Heart Failure, Systolic", "Heart Failure, Diastolic", "Heart Failure，Congestive", "Heart Failure; With Decompensation", "Heart Failure Acute", "Heart Failure With Reduced Ejection Fraction" ], "interventions": [ { "name": "BAMS-HF Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Eastern Colorado Health Care System", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "55 Years to 100 Years" }, "enrollment_count": 29, "start_date": "2020-06-15", "completion_date": "2022-09-14", "has_results": false, "last_update_posted_date": "2023-03-23", "last_synced_at": "2026-10-25T08:17:44.581Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04281849" }, { "nct_id": "NCT00016835", "title": "Treating Periodontal Infection: Effects on Glycemic", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Periodontal Disease", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Supra-gingival scaling and placebo", "type": "PROCEDURE" }, { "name": "Subgingival scaling and metronidazole", "type": "PROCEDURE" }, { "name": "Subgingival scaling and doxycycline", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2001-10-17", "completion_date": "2004-09-03", "has_results": false, "last_update_posted_date": "2017-07-19", "last_synced_at": "2026-10-25T08:17:44.581Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00016835" }, { "nct_id": "NCT02419755", "title": "Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mixed Lineage Acute Leukemia", "Acute Myeloid Leukemia", "Acute Lymphoid Leukemia" ], "interventions": [ { "name": "Bortezomib", "type": "DRUG" }, { "name": "Vorinostat", "type": "DRUG" }, { "name": "Mitoxantrone", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" }, { "name": "Peg-L-Asparaginase", "type": "DRUG" }, { "name": "Erwinia L-Asparaginase", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Mercaptopurine", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "21 Years", "sex": "ALL", "summary": "Up to 21 Years" }, "enrollment_count": 12, "start_date": "2015-04-14", "completion_date": "2016-12-31", "has_results": true, "last_update_posted_date": "2018-03-07", "last_synced_at": "2026-10-25T08:17:44.581Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02419755" } ] }